Compare BCML & CUVL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BCML | CUVL |
|---|---|---|
| Founded | 2004 | 1999 |
| Country | United States | Australia |
| Employees | N/A | 16 |
| Industry | Major Banks | Miscellaneous |
| Sector | Finance | Miscellaneous |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 364.8M | 374.2M |
| IPO Year | 2018 | N/A |
| Metric | BCML | CUVL |
|---|---|---|
| Price | $30.87 | $4.94 |
| Analyst Decision | Hold | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $33.00 | N/A |
| AVG Volume (30 Days) | ★ 55.5K | 5.3K |
| Earning Date | 10-22-2026 | 08-27-2026 |
| Dividend Yield | ★ 3.93% | 0.56% |
| EPS Growth | ★ 3.81 | N/A |
| EPS | ★ 0.11 | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $8.66 | $0.47 |
| Revenue Next Year | $5.59 | $6.25 |
| P/E Ratio | $277.23 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $26.78 | $4.88 |
| 52 Week High | $34.98 | $8.20 |
| Indicator | BCML | CUVL |
|---|---|---|
| Relative Strength Index (RSI) | 52.19 | 42.09 |
| Support Level | $29.69 | $4.91 |
| Resistance Level | $31.13 | $5.40 |
| Average True Range (ATR) | 0.71 | 0.19 |
| MACD | -0.04 | 0.02 |
| Stochastic Oscillator | 62.60 | 36.88 |
BayCom Corp is a bank holding company for United Business Bank. It provides a broad range of financial services to businesses and business owners as well as individuals through its full-service branches and loan production office. The company targets its services to small and medium-sized businesses, professional firms, real estate professionals, nonprofit businesses, labor unions, and related nonprofit entities and businesses, and individual consumers. Its products and services include deposit products, personal accounts, loans, online banking, cash management, and business savings services. The Company operates as one reportable segment: banking operations.
Clinuvel distributes a single product, Scenesse, the only approved treatment for phototoxic reactions specifically associated with a rare genetic disease called erythropoietic protoporphyria. EPP causes extreme pain or burns from brief exposure to light, affecting a patient's quality of life. Scenesse is a patented dissolvable implant, comparable in size with a rice grain, injected underneath the skin roughly every three months for ongoing protection. The implant controls the release of a synthetic drug which promotes the production of more melanin, thereby reducing pain and increasing tolerance for light exposure. The majority of Clinuvel's earnings stem from Europe and the US.